BCL2 and non-small cell lung carcinoma: As to removing phlegm and blood stasis (QuXie) group, ZJF9 (quercetin) was reported to reduce Bcl-2 and enhance apoptosis in NSCLC (Alam et al., 2022), inhibit the proliferation and metastasis of NSCLC via the Fn14/NF-κB pathway (Dong et al., 2020), which was in accordance with the inhibiting Bcl-2 of YFSJ in the present study.